Here are relevant reports on : central-nervous-system-drug-delivery-market

• Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone) PCL), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2029

  The bioresorbable polymers market is expected to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6% during the forecast period. The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).

  • Published: November 2024
  • Price: $ 4950
  • TOC Available:

• Europe Injectable Drug Delivery Market by Product (Device, Self Injection, Formulation, Solution, Emulsions), Formulation Packaging (Ampoules, Bottles), Therapeutic Application (Obesity, Diabetes, Cancer, Psoriasis), Usage Pattern - Forecast to 2031

  The Europe injectable drug delivery market, valued at US$166.13 billion in 2025, stood at US$178.87 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$259.49 billion by the end of the period. The increasing use of biologics, biosimilars, and long-acting injectables is driving market growth. There is an increasing demand for patient-centric delivery systems and self-administration in major healthcare markets.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031

  The Asia Pacific injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period. The growth of the Asia Pacific injectable drug delivery market is driven by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside a rapidly growing patient population and an escalating burden of chronic diseases across major countries in the region.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Europe Medical Tubing Market by Material (Plastics, Rubber, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems), Structure (Single Lumen, Multi Lumen, Co-Extruded, Braided), and Country - Forecast to 2030

  The Europe medical tubing market is projected to grow from USD 3.64 billion in 2025 to USD 5.14 billion by 2030, at a CAGR of 7.1% during the forecast period. The key global players in the Europe medical tubing market are Freudenberg Medical (US), RAUMEDIC AG (Germany), Vygon (France), B. Braun (Germany), Saint-Gobain (France), Trelleborg Medical (Sweden), Teleflex (US), Coloplast (Denmark), Smiths Medical (US), and TE Connectivity (Ireland).

  • Published: January 2026
  • Price: $ 4950
  • TOC Available:

• Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030

  The global liquid handling systems market, valued at US$4.7B in 2024, is forecasted to grow at a 8.0% CAGR, reaching US$ 5.1B by 2025 and US$7.4B by 2030. The increasing trend of outsourcing pharmaceutical research enables businesses to cut costs and obtain specialty expertise. Rising investments in life sciences research and development are helping fuel innovation across the drug discovery and development process.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030

  Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.

  • Published: April 2025
  • Price: $ 4950
  • TOC Available:

• Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030

  Global digital pathology market valued at $1.30B in 2024, reached $1.46B in 2025, and is projected to grow at a robust 13.5% CAGR, hitting $2.75B by 2030. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Home Healthcare Software - Product & Service Market - Application (Clinical, Non - Clinical), Usage (Laptop, Smartphone), Product (Agency, Clinical Management System, Telehealth, Hospice), Delivery (Web - Based, On - Premises, Cloud), End User - Global Forecast to 2018

  The global home healthcare software and services market is estimated to reach $6.4 billion by 2018, at a CAGR of 13.4% between 2013 and 2018. The market will be driven by skyrocketing healthcare cost, spiralling aging population that increases the incidences of chronic disorders, hospital readmission reduction program by U.S., shortage of nursing and doctors staff, OASIS documentation, and favorable government initiatives.

  • Published: May 2014
  • Price: $ 4950
  • TOC Available:

• Clinical Trial Management System Market by Product (Software, Services), Delivery (Web-hosted, On-premise, Cloud-based), Deployment (Enterprise, On-site), End User (Pharma, Medical Device Manufacturers, CROs) & Region - Global Forecast to 2025

  The global clinical trial management system market growth is primed to transition from $801 million in 2020 to $1.59 billion by 2025, showcasing a strong CAGR of 14.7%. The growth of this market is driven by the increasing number of clinical trials and government support for research trials. However, budget constraints and limited knowledge about advanced CTMS solutions restrain the market's growth.

  • Published: January 2021
  • Price: $ 4950
  • TOC Available:

• Learning Management System Market by Delivery Mode (Distance Learning, Instructor-led Learning, Blended Learning), Application Area (Corporate Training & Development, Professional Certification & Compliance, Course Management) - Global Forecast to 2032

  The learning management system market is projected to reach 100.70 billion at a CAGR of 18.4% during the forecast period. The Key Players Anthology (US), Moodle (Australia), Cornerstone OnDemand (US), D2L Corporation (Canada), Instructure Inc. (US), PowerSchool (US), IBM (US), Infor (US), Adobe (US), LTG (UK), Google (US), Oracle (US), SAP (Germany), Docebo (Canada), Learning Pool (UK), Absorb LMS (Canada), CrossKnowledge (France), BizLibrary(US), iSpring (US), Blue Sky eLearn (US), Trakstar (US), DigitalChalk (US), Touvti LMS (US), SkyPrep (Canada), Talent LMS (US), Acorn LMS (Australia), and LearnWorlds (UK).

  • Published: January 2026
  • Price: $ 7150
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50